ADDING MULTIMEDIA FDA Approves KALYDECO (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic ...
Vertex Pharmaceuticals Incorporated announced today that the U.S. Food and Drug Administration has approved KALYDECOTM , the first medicine to treat the underlying cause of cystic fibrosis , a rare, genetic disease.

Device firms, FDA reach deal on new product OKs
The medical device industry agreed to pay the FDA $595 million, which is to be used to accelerate the review process.

Carbendazim In Orange Juice - FDA Informs Juice Products Association
The following is an addendum to a FDA Letter to the Juice Products Association dated January 9, 2012. This information will be updated, as appropriate, on Friday of every week. January 27, 2012 The FDA is currently testing samples of orange juice shipments from all countries and manufacturers that import their products to the U.S. as well as imported and finished products from domestic ...